G20 Global Pharma Summit Series-Mexico

Due to changing market dynamics, the pharmaceutical industry is experimenting with innovative manufacturing methods, such as small batches for precision medicine. Single-use bioreactors are also becoming increasingly popular, as they can reduce downtime and increase production. These bioreactors accomplish this by means of disposing of complex tasks like as cleaning and validation among production rounds. New bioreactor structures and non-stop manufacturing techniques are being developed to cope with the growing emphasis on biopharmaceuticals. Non-stop production, in addition to minimising downtime, has low energy requirements, great productivity, and little waste.